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m963103 ClinicalValidityof NormalCompressionUltrasoundfor SuspectedDeep-VeinThrombosis
inOutpatients
B.G. Birdwell, G.E. Raskob, T.L. Whitsett, S.S. Durica. The LAriversityof
O/dahonraHealth Sciences Cerrteri Oklahoma City O/r/ahorna,USA
Compression ultrasound (C-US) is highly sensitive and specific for proximal
deep-vein thrombosis (DVT) in symptomatic outpatients. However, only lim-
ited data are available on the clinical outcome of patients managed based
on C-US. We perlormed a prospective cohorl study to evaluate the safety
of withholding anticoagulant therapy in outpatients with clinically suspected
first-episode DVT who have normal C-US results. C-US was performed on
presentation, and if normal, repeated ones 5-7 days later. C-US was per-
formed using a simplified exam limited to the common femoral vein and
the popliteal vein extending distally to the trifurcation. Anticoagulants were
withheld in ail patients normal by C-US. The validity of this approach was
tested by follow-up for 3 months. Of 405 consecutive Qatients,70 (17%) were
abnormal by C-US and 335 pstienta remained normal. Of 70 patients with
abnormal results, 63 (90%) were detected at presentation and 7 on repeat
testing. Follow-up for 3 months was completed in all 405 patients. None
were lost to follow-up. None of the 335 patients normal by C-US died from
pulmonary embolism (957. Cl, O to 1.1%). Two had symptomatic venous
thromboembolism confirmed by objective testing (0.6Y0,95% Cl 0.077. to
2.2%). It is safe to withhold anticoagulant therapy in outpatients with sus-
paeted first-episode DVT who are normal by C-US testing.
m963104 PowerDopplerUltrasoundin Detsctionof DespVenousThrombosis
M. Nishino, J. Tanouchi, T. No,Y.Wada, J. Kate, Y. Doi, K. Iwai,
H. Tanahashi, Y.Yamada, T. Kamada. Osaka Rosai f-foapital,Osaka, Japan
Deep venous thrombosis (DVT) sometimes induce life-threatening compli-
cations. Compression ultrasound has been shown a high accuracy in the
diagnosis of DVT, however it is sometimes difficult to compress the vein in
the very obese patients even if they had no DVT.Thus, color Doppler (CD)
ultrasound wee applied to detect DVT, but some repcm have demonstrated
low accuracy of CD. In this study power Doppler (PD) ultrasound, which
recently developed to detect very low velocity flow independent of Doppler
incident angle, was applied to the detection of DVT. Consecutive 70 outpa-
tients with signs of swelling of lower extremity, who were 10 with pulmonary
embolism (PE), 7 with antiphospholipid-antibocfy syndrome (APS) and 53
with idiopathic edema, underwent compression, CD, and PD ultrasound. The
criteria for DVT by each ultrasound method are noncompressibility,absence
ofeolor in vein lumen, and flow defect in vein lumen, respectively.Soon after
ultrasound examinations, venogrephy was performed to diagnose DVT and
the reaults were Comparedwith each ultrasound examination independently.
As a result, venogrsphy reveafed seven DVT patients (10%), in whom 4 had
PE (4410:40%) and 3 had APS (&7: 66%). The sensitivity and specificity of
deteefion of DVT be each ultrasound method was as follows:
Ultrasound Compression CD PD
Sensitivity loim 86% 10D”A
Specificity 97Y. 95% 100%
Compared with compression ultrseound, CD and PD ultrasound are eu-
perior from the point of view of lees demanding and less time-consuming.
However, in CD, the image quality depends on Doppler incident angle and
the image near the vein wall usually poor. These results indicate that power
Doppler ultrasound is an accurate and useful method for detecting DVT
and this method should be performed especiaffy in the outpatients with
edema complicated with pulmonary embolism or antiphospholipid-antibody
syndrome.
1963-1051 ASimpleBSdsideClinical-EchocardiograPhic
AlgorithmisVerySpecificofseverePulmonary
Embolism:A ProspectiveStudyin43Cases
P. Michon, Ph. Asseman, L. Chartier, C. Loubeyre, J.J. Bauchart,
M. Lesenne, Cl. Thery. f-f@ita/ Cardio/ogique, Line, France
A repid bedside noninvasive diagnostic strategy for severe pulmonaty em-
bolism (PE) is still needed. We prospective/y studied the diagnostic value of
a clinical – no preexisting cardiopulmonary disease - and echocardiographic
- a dilated right ventricle (RV) and/or pulmonaty hypertension without left
ventricular (LV) or mitral disease – algorithm. It was tested in 43 patients,
with 27 confirmed PE (pulmona~ angiography and/or isotopic scanning).
Results: 1) In the patients with confirmed PE (n = 27), a) there was a
RV dilatation in 84 percent, b) paradoxical septal motion in 75 percent, c)
thrombus of the right cardiac cavities (RCC) in 18.5 of casee, d) systolic
pulmonary artery pressure was 55 + 12 mmHg. 2) In the patients with RV
dilatation (n = 23), a) diagnosis of PE was made in 91.3 percent (one pre-
viously undetected primary pulmonary hypertension was the rare differential
diagnosis), b) a thrombus of RCC was seen in 21.7 percent of cases. 3) In
the patients without PE (n = 16), a) there was no RV dilatation in 87 percent,
b) septal motion was normal in 85.7 percent, c) there was no thrombus in
RCC in 1~ percent of cases. 4) In the patients with normal RV (n = 17), a)
PE was not diagnosed in 78.5 percent, b) there was no thrombus in the RCC
in 100 percent of cases, 5) Only 3 patients were anechogene (6.9 percent).
Conclusion: 1) A simple bedside clinical-echocardiographic algorithm is
highly specific (87 percent) in identifying severe PE with a positive predictive
value,of 91.3 percent. 2) Conversely, negative predictive value is low (76.5
percent), but patients without echocerdiographic evidence of RV overtoad or
pulmonary hypertension have mild PE, that require further diagnostic etudies,
tailored to their low risk.
m963106 UrokinaseImprovesEndothelium-DependentRelaxationin ExperimentalPulmonaryEmboiiam
W.L. Daley, G.V.R.K. Sharma. West Roxbury WA.Medical Cente~ Brigham,
MA, USA, Women’s Hospital, Harvard Medical School, Boston, MA, USA
We recently obsewed that endothelium-dependent vasodilatation is atten-
uated in experimental pulmona~ embcdism (PE). In order to examine the
effect of urokinase (UK), PE was created in 22 mongrel dogs by injaeting
autologous thrombin-clots into the jugular vein. Selected cine angiograms of
a segmental pulmonary artery (PA) were obtained after infusion of graded
concentrations of acetylcholine (ACh) (10-9 to 1O-g M) followed by an infu-
sion of 40 Kg of nitroglycerin (TNG) into the PA before and after PE and after
an infusion of UK (4400 units/kg in 10 minutes followed by the same dose in
one hour). Percent change in PA diameter was measured ueing quantitative
angiography. Dose response curves obtained from mean values for control,
PE and UK for each infusion of ACh and TNG are displayed.
14: ZF 7
Infusion of ACh after PE attenuated the PA response (p <0.05 control
vs PE), with minimal change in PA diameter. Infusion of UK improved the
attenuated PA response to ACh (p <0.05 UK vs PE). Infusion of TNG, both
before and after UK, produced pulmonary vasodilatation indicating preserved
endothelium-independent relaxation. Conclusion: UK improves the impaired
endothelium-dependent pulmonary vasodilatation in experimental PE.
m963107 RelationBetweenTimeto Achievethe LowerLimitof APTTRangeandRecurrentVenous
Thromboembolismin PatientsWithVenous
Thrombosis
G.E.,Raskob, R.D. Hull, G.F. Pineo, K.A. Valentine, R.F. Bran!. Univereityof
Calgary Calgary Alberta, Canada, University of Oklahoma, Oklahoma City
Oklahoma, USA
Monitoring heparin using the APTTto establish therapeutic doses in patients
with deep-vein thrombosis remains a standard of care. A randomized double
blind trial compared subcutaneous (SC)and intravenous (iv) heparin for initial
treatment. Before the trial, we hypothesized that exceeding the lower limit of
the APTT range was important to clinical outcome. The sc regimen resulted
in an APTT response below the predefine lower Iimitfor 24 hours or more in
38/57 patients (63%) and a high rate of recurrent venous thromboembolism
(VTE, 11/57, 19%); iv heparin resulted in an initial APTTbelow the lower limit
in 17/58 patients (29%) (p < 0.001) and reduced recurrent VTE (3/58, 5%)
(p= 0.024).
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Analysisof time to achieve the APTT lower limit (figure) not previously
reported shows the sc regimen failed to achieve the lower limit by 24 to
48 hours in many patients, whereaa iv heparin did so early in moat (p =
0.004). Achieving an APIT above the lower limit early is important to clinical
outcome.
El964 Interaction of Lipid Moities With Biochemical
Mediators
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]964-64/ increasedLipolYsi*~f~rigiYceride-Ri~h
LipoproteinsEnhancesArteryWallPermeability
andLipoproteinRetention
G. Gardner, M. Woo, 1.Goldberg, J.C. Rutledge. Universityof Ca/iforrriat
Davis,Davis,CA,USA,ColumbiaCollegeof Physiciansand.%rgeons,
NewYork,NY,USA
Triglyceride-rich lipoproteins (TGRL: chylomicrons, VLDLand IDL) are asso-
ciated with atherosclerosis; however, the mechanism promoting this effect
are largely unknown. Our goal was to examine the effect of increased lipol-
ysis on TGRL remnant flux in the artery wall. We measured fluorescently
labeled TGRL flux in rat carotid artery walls by quantitative fluorescence mi-
croscopy.The rate of accumulation (N/t) and the half life for TGRL efflux from
the artery wall (TIIZ) waa determined for each perfusion (n= 30 perfusions).
The average N/t for control TGRL perfusion was 0.16+ 0,08 mV/min. After
treatment with lipoprotein Iipase (LPL, 10 KM), the rate of TGRL accumu-
lation increased to 0.38 & 0.14 mV/min (p = 0.03). T117.for TGRL remnant
efflux from the aflery wall was 3.39 + 0.47 min during control and 4.89 +
1.24 min after addition of LpL. The reduction in TGRL remnant efflux indi-
cates increased retention in the artary wall. To further assess permeability,
hypertriglyceridemic human plasma was perfused into individual carotid ar-
teries, and flux of a fluorescently labeled water-soluble referance molacule
(dextran; 78,000 MW) was measured before and after adding LPL(10 KM) to
the perfusate. Addition of LPL significantly increased dextren accumulation
indicating increased endothelial layer permeability (0.24 + 0.1 mV/min vs.
0,9S + 0.5 mV/min). Our atudies indicate that high levels of Iipolysis pro-
mote increased endothelial layer permeability and lipoprotein accumulation.
These effects could potentate increased modification of TGRLremnants and
promote atherogenesis.
D96465 MitogenicEffectof SerotoninonVascularSmooth
Muscle Cells is Potentiated by Low Density
Lipoproteins
S.Koba, R. Pakaia; T. Katagiri, C. Benedict. TheUniversityof Texas,
Houston,TX,USA
Seclrgmund:Whsther Iowdensify lipoprotein (LOL) has amitogenic effeeton
smooth muacle cells (SMC) has been controversial. Since platalet aggrega-
tion at sites of atherosclerotic injury exposee the cells to high eoncantretion
of serotonin (5HT), a known mitogen for SMC, we axamined whethar LOL or
mildly Oxidized LDL (OX-LDL) can potentate the mitogenic efeef of 5HT on
SMC.
Methods: Primaty ao!tic rabbit SMC were grown in 10% and then 0.1%
fetal bovine serum for 72 houra. Then cells were incubated with different
concentrations of LDL or OX:LDL (mild oxidation of LDL was induced by
incubation with Cu++ which increased the thiobarbituric acid products (=
30 .pmol/mg protein) with no change in electrophoretic mobility) for 24 hrs
followed by incubation with 5HT for 24 hre. The amount of 3H-thymidine
incorporated into the ONA was then meaaurad.
o 50
5HT concentration (pM)
Resu/ts: LDL or mildly OX-LDL induced significant SMC proliferation by
themselves and this effact was potantlated by 5HT.
Corrchdorr:Thase results suggest that increased concentrations of LOL
or mildly OX-LDL may potentate the mitogenic effect of 5HT that is released
by aggregating platelets at sites of vascular damage.
M synergis’’cAugm’”~tionof =pr~ssioflof
Plasminogen Activator Inhlbltor Type I (PAI-1) in
Human Hepatoma (HepG2) Cella by Insulin and
Fatty Acids
D.J. Schneider, BE. Sobel. Univarsifyof Vermont,Burlington,Vermont,
USA
Cardiovascular mortality in patients with type II diabetes Is increased 4- to
8-fold. In addition to incraasad concentration in blcmd of inaulln, VLDL-
triglyceride (TG), and free fatty acids (FFAs) bound to albumin, PAI-I is
incraasad. To determine interactions, accumulation of PAI-1 in media mndi-
tloned by HepG2 cells was characterized in response to VLDL-Tr3, FFAa,and
insulin alone and in combination. 24-hour accumulation of PAI-I correlated
closely with the concentration of VLDL-TG (isolated from plasma of subjects
with or without type II diabetes, r = 0.91, p < 0.01). By contrast, there was
no significant correlation between VLDL-protein and accumulation of PAI-1.
Increasas in accumulation of PAI-1 in response to insulin with VLDL-TG were
synergistic as determined by the isobol and median affect methoda (e.g.
control = 30 + 2, VLDL-TG 200 mg/dl = 118 + 17, 2 nM insulin = 45 + 2,
combination = 172 + 25, p <0.01 for each). Exposure of HepG2 cells to
albumin-bound FFAs in combination with insulin reauked in aynergy aa well
(e.g. control =27 +3, 1 mM FFA38 +2, 10 nM insulin =59+ 8*, combination
=82 + 1*, ” p < 0.01). Accotdingiy, the increased concentrations of insulin,
VLOL-TGand FFAs in patients with type II diabetes may contribute toveecu-
Iopathy underlying the increased cardiovascular mortality by synergiaticelly
stimulating hepatic expression of PAI-1 consequently inhibiting a fibrinolytic
response to formation of microthrombi and occlusive thrombi.
1- platelet-~ependent~hrombin~enerationin
Patients with Hypercholesterolemia
K, Kawano, 1.Aoki, N. Aoki, K. Shimoyama, A. Maki, M. Homori,
A. Yanagisawa, Y. Kawai 1, K. Ishikawa. KyorinUniversityTokyo,Japan,
1KeioUniversityTokyo,Japan
Objectives:Coagulability was comoered before and after treatment with
pravastatin in hy~ercholesterolemicpatients by measuring theplatelet-dependent
thrombin generation to assess its value ae an index of atheroecleroeis and
to comfirm the importance of managing hyperlipidemia. Methods: Platelet-
dependent thrombin generation was measured uaing the method of Aron-
son et al. (Circulation 1992) Briefly, platelet-rich plaama (150 x IOg/L) wee
prepared and 40 mmol/L of CaC12was added to initiate clotting. S-2236
was added to each sample in a microtiter plate every 10 minutes, and the
absorbance of the relaased color product at 2 minutes was measured apac-
trophotometrically at a wavelength of 405 nm using a microtiter plate reader
to quantify the thrombin generation. Platelet-dependent thrombin generation
was measured in 51 patients (18 men, 85 women, age 59.1 + 1.7 yeara;
mean + S.E.) with hypercholesterolemia (serum total cholesterol level >
5.69 mmol/L) before and after treatment with pravastetin and in 82 nor-
mal subjects. Resufts:The thrombin generation at 30 minutea wae higher
in the pra-treated hypercholesterolamic patients as compared with that in
the control subjects (372 + 39 versus 114 + 19 mU/ml; mean + S.E., p
< 0.001). Thrombin generation in theae patients approached that of the
controls after treatment with prevastatin (180 + 27 mU/ml, pre-treatment
versus post-treatment, p < 0.001). Cone/usions:Thesedate indicate that (1)
platelet-dependent thrombin generation ia elevated in patients with hyperc-
